Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vermylen

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
European Journal of Pediatrics|August 1, 1986
A variant of the congenital dyserythropoietic anaemia type II with structural abnormalities in the granulocytic seriesC Vermylen, J M Scheiff, J Rodhain, et al.
European Journal of Pediatrics|May 1, 1994
Haematological disturbances during long-term valproate therapyB Brichard, C Vermylen, J M Scheiff, et al.
Lancet (London, England)|July 25, 1992
Evaluation of anti-HCV capsid indeterminate serum samplesH Claeys, A Volkaerts, H Verhaert, et al.
European Journal of Pediatrics|April 1, 1983
The wandering spleenC Vermylen, P Lebecque, D Claus, et al.
Pediatric Hematology and Oncology|January 1, 1990
Familial essential thrombocythemiaE Fernandez-Robles, C Vermylen, P Martiat, et al.
Clinical and Laboratory Haematology|June 1, 1997
An EIA method on single donor solubilized HLA antigens for the identification of anti-HLA antibodiesM P Emonds, H Claeys, A Volckaerts, et al.
Acta Clinica Belgica|January 1, 1993
Plasma infusion as treatment for 33 children with haemolytic uraemic syndrome: a good therapy?B Brichard, C Vermylen, M T Heremans, et al.
Journal of Pediatric Hematology/Oncology|February 24, 2001
Smooth muscle tumor developing in an immunocompromised child after therapy for leukemiaB Brichard, C Vermylen, S Gosseye, et al.
Lancet (London, England)|August 30, 1975
Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patientsJ Desmyter, A F Bradburne, C Vermylen, et al.
Journal of Clinical Microbiology|May 1, 1989
Yersinia enterocolitica in donor blood: a case report and reviewJ Jacobs, D Jamaer, J Vandeven, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Pediatrics|August 1, 1986
A variant of the congenital dyserythropoietic anaemia type II with structural abnormalities in the granulocytic seriesC Vermylen, J M Scheiff, J Rodhain, et al.
European Journal of Pediatrics|May 1, 1994
Haematological disturbances during long-term valproate therapyB Brichard, C Vermylen, J M Scheiff, et al.
Lancet (London, England)|July 25, 1992
Evaluation of anti-HCV capsid indeterminate serum samplesH Claeys, A Volkaerts, H Verhaert, et al.
European Journal of Pediatrics|April 1, 1983
The wandering spleenC Vermylen, P Lebecque, D Claus, et al.
Pediatric Hematology and Oncology|January 1, 1990
Familial essential thrombocythemiaE Fernandez-Robles, C Vermylen, P Martiat, et al.
Clinical and Laboratory Haematology|June 1, 1997
An EIA method on single donor solubilized HLA antigens for the identification of anti-HLA antibodiesM P Emonds, H Claeys, A Volckaerts, et al.
Acta Clinica Belgica|January 1, 1993
Plasma infusion as treatment for 33 children with haemolytic uraemic syndrome: a good therapy?B Brichard, C Vermylen, M T Heremans, et al.
Journal of Pediatric Hematology/Oncology|February 24, 2001
Smooth muscle tumor developing in an immunocompromised child after therapy for leukemiaB Brichard, C Vermylen, S Gosseye, et al.
Lancet (London, England)|August 30, 1975
Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patientsJ Desmyter, A F Bradburne, C Vermylen, et al.
Journal of Clinical Microbiology|May 1, 1989
Yersinia enterocolitica in donor blood: a case report and reviewJ Jacobs, D Jamaer, J Vandeven, et al.
Pageof 11